News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

EU approves Novartis eye drug for new use

Started by riky, July 06, 2013, 09:00:20 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

EU approves Novartis eye drug for new use

<p><a href="http://news.yahoo.com/eu-approves-novartis-eye-drug-061824050.html"><img src="http://l.yimg.com/bt/api/res/1.2/W8hFUMqSYgt7acgu8IMAYw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-07-05T061824Z_1_CBRE9640HIS00_RTROPTP_2_INDIA-NOVARTIS-PATENTS.JPG" width="130" height="86" alt="A man speaks on a telephone inside Novartis India headquarters in Mumbai" align="left" title="A man speaks on a telephone inside Novartis India headquarters in Mumbai" border="0" /></a>ZURICH (Reuters) - Swiss drugmaker Novartis' eye drug Lucentis has been approved as a treatment for a further condition related to worsening eyesight by the European Union, adding to three other conditions for which it is already approved. The Basel-based drugmaker said the European Commission had granted approval for Lucentis to treat patients with visual impairment due to choroidal neovascularization (CNV) secondary to pathologic myopia. Lucentis, which was first launched in 2006, is an important product for Novartis and had sales of $2.4 billion in 2012. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login